Thursday - December 11, 2025
Second Schizophrenia Treatment Discovered at Vanderbilt's Warren Center Enters Phase I Clinical Trial
November 13, 2025
NASHVILLE, Tennessee, Nov. 13 -- Vanderbilt University School of Medicine Basic Sciences issued the following news:

* * *

Second schizophrenia treatment discovered at Vanderbilt's Warren Center enters Phase I clinical trial

A new potential treatment for schizophrenia discovered through the Warren Center for Neuroscience Drug Discovery has entered Phase 1 clinical trials, marking the fifth WCNDD therapeutic to advance into human testing.

Th . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products